Cogent Biosciences Company
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Funding Status:
IPO
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2014
Employee Number:
101-250
Last Funding Type:
Post-IPO Equity
Total Funding:
282700000
Industry:
Gene therapy